Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas

Jordi Rodon; Anna Z Mykytyn; Guillermo Cantero; Irina C Albulescu; Berend-Jan Bosch; Alexander Brix; Jean-Christophe Audonnet; Albert Bensaid; Júlia Vergara-Alert; Bart L Haagmans; Joaquim Segalés

doi:10.1186/s42522-022-00068-9

Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas

Jordi Rodon, Anna Z Mykytyn, Guillermo Cantero, Irina C Albulescu, Berend-Jan Bosch, Alexander Brix, Jean-Christophe Audonnet, Albert Bensaid, Júlia Vergara-Alert, Bart L Haagmans, Joaquim Segalés

Virology

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Ongoing outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) continue posing a global health threat. Vaccination of livestock reservoir species is a recommended strategy to prevent spread of MERS-CoV among animals and potential spillover to humans. Using a direct-contact llama challenge model that mimics naturally occurring viral transmission, we tested the efficacy of a multimeric receptor binding domain (RBD) particle-display based vaccine candidate. While MERS-CoV was transmitted to naïve animals exposed to virus-inoculated llamas, immunization induced robust virus-neutralizing antibody responses and prevented transmission in 1/3 vaccinated, in-contact animals. Our exploratory study supports further improvement of the RBD-based vaccine to prevent zoonotic spillover of MERS-CoV.

Original language	English
Article number	12
Pages (from-to)	1-5
Journal	One Health Outlook
Volume	4
Issue number	1
DOIs	https://doi.org/10.1186/s42522-022-00068-9
Publication status	Published - 24 Jun 2022

Bibliographical note

Keywords

Animal model
Camelid
Llama
MERS-CoV
Middle East respiratory syndrome coronavirus
Multimeric protein scaffold particles (MPSP)
Neutralizing antibodies
Receptor binding domain (RBD)-based vaccine
Virus transmission

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s42522-022-00068-9Licence: CC BY

s42522-022-00068-9Final published version, 1.39 MBLicence: CC BY

Cite this

Rodon, J., Mykytyn, A. Z., Cantero, G., Albulescu, I. C., Bosch, B.-J., Brix, A., Audonnet, J.-C., Bensaid, A., Vergara-Alert, J., Haagmans, B. L., & Segalés, J. (2022). Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas. One Health Outlook, 4(1), 1-5. Article 12. https://doi.org/10.1186/s42522-022-00068-9

@article{1ac76022231146b1833479eb74fce6d8,

title = "Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas",

abstract = "Ongoing outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) continue posing a global health threat. Vaccination of livestock reservoir species is a recommended strategy to prevent spread of MERS-CoV among animals and potential spillover to humans. Using a direct-contact llama challenge model that mimics naturally occurring viral transmission, we tested the efficacy of a multimeric receptor binding domain (RBD) particle-display based vaccine candidate. While MERS-CoV was transmitted to na{\"i}ve animals exposed to virus-inoculated llamas, immunization induced robust virus-neutralizing antibody responses and prevented transmission in 1/3 vaccinated, in-contact animals. Our exploratory study supports further improvement of the RBD-based vaccine to prevent zoonotic spillover of MERS-CoV.",

keywords = "Animal model, Camelid, Llama, MERS-CoV, Middle East respiratory syndrome coronavirus, Multimeric protein scaffold particles (MPSP), Neutralizing antibodies, Receptor binding domain (RBD)-based vaccine, Virus transmission",

author = "Jordi Rodon and Mykytyn, {Anna Z} and Guillermo Cantero and Albulescu, {Irina C} and Berend-Jan Bosch and Alexander Brix and Jean-Christophe Audonnet and Albert Bensaid and J{\'u}lia Vergara-Alert and Haagmans, {Bart L} and Joaquim Segal{\'e}s",

note = "{\textcopyright} 2022. The Author(s).",

year = "2022",

month = jun,

day = "24",

doi = "10.1186/s42522-022-00068-9",

language = "English",

volume = "4",

pages = "1--5",

journal = "One Health Outlook",

issn = "2524-4655",

publisher = "BMC",

number = "1",

}

TY - JOUR

T1 - Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas

AU - Rodon, Jordi

AU - Mykytyn, Anna Z

AU - Cantero, Guillermo

AU - Albulescu, Irina C

AU - Bosch, Berend-Jan

AU - Brix, Alexander

AU - Audonnet, Jean-Christophe

AU - Bensaid, Albert

AU - Vergara-Alert, Júlia

AU - Haagmans, Bart L

AU - Segalés, Joaquim

PY - 2022/6/24

Y1 - 2022/6/24

N2 - Ongoing outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) continue posing a global health threat. Vaccination of livestock reservoir species is a recommended strategy to prevent spread of MERS-CoV among animals and potential spillover to humans. Using a direct-contact llama challenge model that mimics naturally occurring viral transmission, we tested the efficacy of a multimeric receptor binding domain (RBD) particle-display based vaccine candidate. While MERS-CoV was transmitted to naïve animals exposed to virus-inoculated llamas, immunization induced robust virus-neutralizing antibody responses and prevented transmission in 1/3 vaccinated, in-contact animals. Our exploratory study supports further improvement of the RBD-based vaccine to prevent zoonotic spillover of MERS-CoV.

AB - Ongoing outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) continue posing a global health threat. Vaccination of livestock reservoir species is a recommended strategy to prevent spread of MERS-CoV among animals and potential spillover to humans. Using a direct-contact llama challenge model that mimics naturally occurring viral transmission, we tested the efficacy of a multimeric receptor binding domain (RBD) particle-display based vaccine candidate. While MERS-CoV was transmitted to naïve animals exposed to virus-inoculated llamas, immunization induced robust virus-neutralizing antibody responses and prevented transmission in 1/3 vaccinated, in-contact animals. Our exploratory study supports further improvement of the RBD-based vaccine to prevent zoonotic spillover of MERS-CoV.

KW - Animal model

KW - Camelid

KW - Llama

KW - MERS-CoV

KW - Middle East respiratory syndrome coronavirus

KW - Multimeric protein scaffold particles (MPSP)

KW - Neutralizing antibodies

KW - Receptor binding domain (RBD)-based vaccine

KW - Virus transmission

U2 - 10.1186/s42522-022-00068-9

DO - 10.1186/s42522-022-00068-9

M3 - Article

C2 - 35739576

SN - 2524-4655

VL - 4

SP - 1

EP - 5

JO - One Health Outlook

JF - One Health Outlook

IS - 1

M1 - 12

ER -

Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this